The market opened in green on September 25, 2020.

The market opened in green on September 25, 2020, overall volumes in futures & options currently stand at 6,71,01,341 crore contracts with a turnover of Rs. 43,02,566.44 crore.

Cipla Limited today announced that it has received final approval for its abbreviated new drug application (ANDA) for Dimethyl Fumarate DR Capsules 120mg, 240mg, and 120mg/240mg starter pack from United States Food & Drug Administration (USFDA).

The onus is on the 200-DMA, which is placed at 10,761. If bulls manage to defend it, expect a pullback up to the levels of 10,980, or else, 10,640-10,550 is the next destination. Stocks in news: Cipla, GMR Infrastructure, ONGC, GAIL, RITES, TCS.

The Indian markets are gripped by three key factors namely, fear, uncertainty, and doubt. The fear is rising as it is quite evident from the surge in India VIX. Uncertainty is hovering over as some countries are planning another lockdown to combat the spread of Coronavirus and doubt over the pace of economic recovery.

As of now BSE's flagship index – Sensex 50 is traded on India International Exchange (India INX) and is catching trader's attention. The total turnover on the India INX is increasing steadily and has reached USD 57.7 billion in August 2020, with a market share of 57 per cent against comparable index in Singapore. There are as many as 100 proprietary traders active on the exchange and more than 40 members are currently active with more members awaiting the regulatory approvals.

The leading fast‐moving electrical goods (FMEG) company, Havells India Limited, informed the bourses on Thursday that it has entered into the refrigerator segment under its consumer durable brand-Lloyd.

The share price of the global generic, speciality pharmaceutical & vaccine maker, Panacea Biotec, hits 5 per cent upper circuit on BSE today during the afternoon session.

Zydus Cadila is said to market Palbociclib capsules (US RLD: Ibrance capsules) in the strengths of 75 mg, 100 mg, and 125 mg. The drug interferes with the growth and spread of cancer cells in the body.

On Thursday, the domestic markets spooked investors as Sensex crashed by 1,114.82 points or 2.96 to close at 36,553.60 levels while Nifty declined by 326.30 points or 2.93 per cent to settle at 10,805.55 levels.